← Leaderboards
Eric T Choi
Washington University
$1,929,407
Attributed
$3,776,298
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $703.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,776,298 · 3
By mechanism
R01$2,775,423 · 1
K08$582,875 · 1
R21$418,000 · 1
Top collaborators
- Xiao-Feng Yang5 shared
- Hong Wang4 shared
Most similar at Washington University
Same institution · by research overlap
- Gregory J Zipfel$13,783,497
- James A Delmez$1,935,693
- Vineet Gupta$8,266,585
- Donald L Elbert$2,449,761
- Patrick M Winter$717,262
Others in their field
Top investigators on “Vascular Smooth Muscle”
- Gary K Owens · University Of Virginia$31,062,822
- Thomas None Quertermous · Stanford University$24,589,588
- Marlene Rabinovitch · Stanford University$23,497,392
- Jason X.-J. Yuan · University Of California, San Diego$22,617,295
- Piero Anversa · New York Medical College$21,454,448
- Bradford C Berk · University Of Rochester$20,612,601
Research focus
Vascular Smooth MuscleChronic Kidney FailureBlood VesselsInhibitor/AntagonistAccountingPreventPatternPublic Health RelevanceCytokineCessation Of LifeChemokineAortaApolipoprotein EEndothelial CellsCell TypeCasp1 GeneCellular PathologyAdultAccelerationCardiovascular SystemAngiopoietinsCellsAtherosclerosisCalcification Inhibitor
Grant awards (13)
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2019 · HL
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2018 · HL
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$703,248
R01 · FY2017 · HL
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$645,335
R01 · FY2016 · HL
Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis$20,344
R01 · FY2016 · HL
A NOVEL APPROACH TO PREVENT ARTERIOVENOUS ACCESS FAILURE IN HEMODIALYSIS PATIENTS$140,494
R21 · FY2010 · HL · contact PI
A NOVEL APPROACH TO PREVENT ARTERIOVENOUS ACCESS FAILURE IN HEMODIALYSIS PATIENTS$87,506
R21 · FY2010 · HL · contact PI
A NOVEL APPROACH TO PREVENT ARTERIOVENOUS ACCESS FAILURE IN HEMODIALYSIS PATIENTS$190,000
R21 · FY2009 · HL · contact PI
Collagen-Binding Integrins in Intimal Hyperplasia$116,575
K08 · FY2006 · HL · contact PI
Collagen-Binding Integrins in Intimal Hyperplasia$116,575
K08 · FY2005 · HL
Collagen-Binding Integrins in Intimal Hyperplasia$116,575
K08 · FY2004 · HL
Collagen-Binding Integrins in Intimal Hyperplasia$116,575
K08 · FY2003 · HL
Collagen-Binding Integrins in Intimal Hyperplasia$116,575
K08 · FY2002 · HL